United States Cell and Gene Therapy Manufacturing QC Market Size & Outlook, 2025-2028
United States Cell and Gene Therapy Manufacturing QC Market Size
According to Straits Research analysis, the United States Cell and Gene Therapy Manufacturing QC Market was valued at USD 792.14 Million in 2024 and is projected to reach USD 1931.44 Million by 2028, expanding at a CAGR of 25% during the forecast period. The biopharmaceutical and medical research industries, particularly in innovative treatments like cancer immunotherapy and regenerative medicine, are primary catalysts for this growth. Advancements in molecular biology and genetic engineering are key drivers, especially in the agriculture and chemical sectors. Amidst the rise of green production and focus on sustainability, the market's impetus lies in low-carbon production technologies. Moreover, emerging trends like the use of AI/ML in quality control (QC) show promising export potential. As the U.S. continues to dominate in technology and scientific R&D, it strengthens its footprint in this essential biomedical market segment.
Source: Straits Research Analysis Company Publications, Primary Interviews.
United States Cell and Gene Therapy Manufacturing QC Market Highlights
- By 2024, Cell Therapy represented the largest share of the Therapy Type market size.
- Gene Therapy is expected to remain the key growth driver within Therapy Type, registering the fastest CAGR during the forecast period.
- As of 2024, United States held 35.43% of the global cell and gene therapy manufacturing qc market size.
- By 2028, United States is anticipated to capture the largest share of the global cell and gene therapy manufacturing qc market.
- In North America, United States is expected to lead the regional cell and gene therapy manufacturing qc market size by 2028.
- Canada will remain the fastest-growing market in North America, reaching USD 24106 Million by 2028.
- 📊 Preview Report Scope and Structure – Gain immediate visibility into key topics, market segments, and data frameworks covered.
- 📥 Evaluate Strategic Insights – Access selected charts, statistics, and analyst-driven commentary derived from the final report deliverables.
Report Summary
| Report Scope | Details |
|---|---|
| Base Year for Study | 2024 |
| Study Period | 2021-2028 |
| Historical Period | 2021-2023 |
| Forecast Period | 2025-2028 |
| Market Size In 2024 | USD 792.14 Million |
| Market Size In 2028 | USD 1931.44 Million |
| Largest segment | Cell Therapy |
| Fastest segment | Gene Therapy |
| Units | Revenue in USD Million |
| CAGR | 25% (2025-2028) |
| Report Coverage | Revenue Forecast, Competitive Landscape, Growth Factors, Environment & Regulatory Landscape and Trends |
United States Cell and Gene Therapy Manufacturing QC Market Share By Therapy Type
Segmentation Covered
| Segments | Sub Segments |
|---|---|
| Therapy Type |
|
| Cell Therapy |
|
| CAR-T |
|
| Gene Therapy |
|
| Viral |
|
| Scale |
|
| Mode |
|
| Workflow |
|
| Process |
|
| End User |
|
| Pharmaceutical Companies |
|
| Biopharmaceutical / Biotechnological Companies |
|
| Contract Manufacturing Organizations |
|
| Technology Type |
|
United States Cell and Gene Therapy Manufacturing QC Market By Therapy Type 2028
Source: Straits Research Analysis Company Publications, Primary Interviews.
United States Cell and Gene Therapy Manufacturing QC Market By Cell Therapy 2028
Source: Straits Research Analysis Company Publications, Primary Interviews.
United States Cell and Gene Therapy Manufacturing QC Market By CAR-T 2028
Source: Straits Research Analysis Company Publications, Primary Interviews.
United States Cell and Gene Therapy Manufacturing QC Market By Gene Therapy 2028
Source: Straits Research Analysis Company Publications, Primary Interviews.
United States Cell and Gene Therapy Manufacturing QC Market By Viral 2028
Source: Straits Research Analysis Company Publications, Primary Interviews.
United States Cell and Gene Therapy Manufacturing QC Market By Scale 2028
Source: Straits Research Analysis Company Publications, Primary Interviews.
United States Cell and Gene Therapy Manufacturing QC Market By Mode 2028
Source: Straits Research Analysis Company Publications, Primary Interviews.
United States Cell and Gene Therapy Manufacturing QC Market By Workflow 2028
Source: Straits Research Analysis Company Publications, Primary Interviews.
United States Cell and Gene Therapy Manufacturing QC Market By Process 2028
Source: Straits Research Analysis Company Publications, Primary Interviews.
United States Cell and Gene Therapy Manufacturing QC Market By End User 2028
Source: Straits Research Analysis Company Publications, Primary Interviews.
United States Cell and Gene Therapy Manufacturing QC Market By Pharmaceutical Companies 2028
Source: Straits Research Analysis Company Publications, Primary Interviews.
United States Cell and Gene Therapy Manufacturing QC Market By Biopharmaceutical / Biotechnological Companies 2028
Source: Straits Research Analysis Company Publications, Primary Interviews.
United States Cell and Gene Therapy Manufacturing QC Market By Contract Manufacturing Organizations 2028
Source: Straits Research Analysis Company Publications, Primary Interviews.
United States Cell and Gene Therapy Manufacturing QC Market By Technology Type 2028
Source: Straits Research Analysis Company Publications, Primary Interviews.
